- Home
- CRBP vs SATX Comparison
CRBP vs SATX Comparison
Compare CRBP & SATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- SATX
- Stock Information
- Founded
- CRBP 2009
- SATX 2012
- Country
- CRBP United States
- SATX Israel
- Employees
- CRBP N/A
- SATX N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- SATX Radio And Television Broadcasting And Communications Equipment
- Sector
- CRBP Health Care
- SATX Technology
- Exchange
- CRBP Nasdaq
- SATX Nasdaq
- Market Cap
- CRBP 143.7M
- SATX 130.6M
- IPO Year
- CRBP N/A
- SATX N/A
- Fundamental
- Price
- CRBP $11.93
- SATX $1.44
- Analyst Decision
- CRBP Strong Buy
- SATX Strong Buy
- Analyst Count
- CRBP 8
- SATX 2
- Target Price
- CRBP $62.00
- SATX $2.25
- AVG Volume (30 Days)
- CRBP 256.8K
- SATX 461.3K
- Earning Date
- CRBP 03-11-2025
- SATX 02-14-2025
- Dividend Yield
- CRBP N/A
- SATX N/A
- EPS Growth
- CRBP N/A
- SATX N/A
- EPS
- CRBP N/A
- SATX N/A
- Revenue
- CRBP N/A
- SATX $10,351,000.00
- Revenue This Year
- CRBP N/A
- SATX $80.62
- Revenue Next Year
- CRBP N/A
- SATX N/A
- P/E Ratio
- CRBP N/A
- SATX N/A
- Revenue Growth
- CRBP N/A
- SATX N/A
- 52 Week Low
- CRBP $7.30
- SATX $0.33
- 52 Week High
- CRBP $61.90
- SATX $2.39
- Technical
- Relative Strength Index (RSI)
- CRBP 39.08
- SATX 52.89
- Support Level
- CRBP $11.02
- SATX $1.21
- Resistance Level
- CRBP $13.28
- SATX $1.57
- Average True Range (ATR)
- CRBP 0.74
- SATX 0.33
- MACD
- CRBP 0.16
- SATX -0.04
- Stochastic Oscillator
- CRBP 40.27
- SATX 19.63
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd develops end-to-end next-generation satellite communications systems, including satellite payloads, user terminals and modems, based on powerful chipsets that it develops in house. Its products include modems that feature Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the advanced communications standard DVB-S2X. Geographical presence in U.S, Canada, UK and Other countries. Majority of its company revenue comes from U.S and Canada.